Recurrence of primary aldosteronism after percutaneous ethanol injection

Adrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report...

Full description

Bibliographic Details
Main Authors: Fan-Chi Chang, Kao-Lang Liu, Kuo-How Huang, Vin-Cent Wu, Yen-Hung Lin, Yung-Ming Chen, Kwan-Dun Wu, TAIPAI Study Group
Format: Article
Language:English
Published: Elsevier 2012-03-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664612000290
_version_ 1818364511173738496
author Fan-Chi Chang
Kao-Lang Liu
Kuo-How Huang
Vin-Cent Wu
Yen-Hung Lin
Yung-Ming Chen
Kwan-Dun Wu
TAIPAI Study Group
author_facet Fan-Chi Chang
Kao-Lang Liu
Kuo-How Huang
Vin-Cent Wu
Yen-Hung Lin
Yung-Ming Chen
Kwan-Dun Wu
TAIPAI Study Group
author_sort Fan-Chi Chang
collection DOAJ
description Adrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report on a man who was 49 years of age and presented with treatment-resistant hypertension and was later diagnosed with APA. CT-guided percutaneous ethanol injection (PEI) was performed for this high surgical risk patient. He had aldosteronism recurrence 4 years after the ethanol injection, so a second PEI was performed. The tumor size was reduced and his blood pressure was normalized. Therefore, we suggest that clinicians should closely check aldosterone to renin ration and potassium level if percutaneous chemical ablation is considered in functioning adrenal adenomas.
first_indexed 2024-12-13T22:05:32Z
format Article
id doaj.art-72438d3d445f4f528fb8d1d3a4f5077f
institution Directory Open Access Journal
issn 0929-6646
language English
last_indexed 2024-12-13T22:05:32Z
publishDate 2012-03-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj.art-72438d3d445f4f528fb8d1d3a4f5077f2022-12-21T23:29:51ZengElsevierJournal of the Formosan Medical Association0929-66462012-03-01111317617810.1016/j.jfma.2012.01.009Recurrence of primary aldosteronism after percutaneous ethanol injectionFan-Chi Chang0Kao-Lang Liu1Kuo-How Huang2Vin-Cent Wu3Yen-Hung Lin4Yung-Ming Chen5Kwan-Dun Wu6TAIPAI Study Group7Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Medical Imaging, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Urology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanTaiwan Primary Aldosteronism Investigation (TAIPAI) Study Group, TaiwanAdrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report on a man who was 49 years of age and presented with treatment-resistant hypertension and was later diagnosed with APA. CT-guided percutaneous ethanol injection (PEI) was performed for this high surgical risk patient. He had aldosteronism recurrence 4 years after the ethanol injection, so a second PEI was performed. The tumor size was reduced and his blood pressure was normalized. Therefore, we suggest that clinicians should closely check aldosterone to renin ration and potassium level if percutaneous chemical ablation is considered in functioning adrenal adenomas.http://www.sciencedirect.com/science/article/pii/S0929664612000290adrenal adenomaaldosterone-producing adenomapercutaneous ethanol injectionprimary aldosteronism
spellingShingle Fan-Chi Chang
Kao-Lang Liu
Kuo-How Huang
Vin-Cent Wu
Yen-Hung Lin
Yung-Ming Chen
Kwan-Dun Wu
TAIPAI Study Group
Recurrence of primary aldosteronism after percutaneous ethanol injection
Journal of the Formosan Medical Association
adrenal adenoma
aldosterone-producing adenoma
percutaneous ethanol injection
primary aldosteronism
title Recurrence of primary aldosteronism after percutaneous ethanol injection
title_full Recurrence of primary aldosteronism after percutaneous ethanol injection
title_fullStr Recurrence of primary aldosteronism after percutaneous ethanol injection
title_full_unstemmed Recurrence of primary aldosteronism after percutaneous ethanol injection
title_short Recurrence of primary aldosteronism after percutaneous ethanol injection
title_sort recurrence of primary aldosteronism after percutaneous ethanol injection
topic adrenal adenoma
aldosterone-producing adenoma
percutaneous ethanol injection
primary aldosteronism
url http://www.sciencedirect.com/science/article/pii/S0929664612000290
work_keys_str_mv AT fanchichang recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection
AT kaolangliu recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection
AT kuohowhuang recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection
AT vincentwu recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection
AT yenhunglin recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection
AT yungmingchen recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection
AT kwandunwu recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection
AT taipaistudygroup recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection